[e-med] (3)Le Nigeria va produire des ARV

[marie de cenival <marie2c@free.fr>]

E-MED:(3)Le Nigeria va produire des ARV
---------------------------------------------------------------------

Confirmé par divers temoignages dans differents centres de suivi du pays :
enfin de bonnes nouvelles du Nigeria, par la tres professionnelle Olayide
Akani de Journalists Against Aids. Je traduit en gros.

"Finalement, un nouvel approvisionnement arrive. Le responable du programme
est remplace."

Par Olayide Akanni
Access Alert newsletter
anuary/February 2004

Apres plusieurs mois de penurie, de nouveaux stocks d'antiviraux abreuvent
un programme chancelant. Les traitements devraient parvenir dans les 25
centres de dispensation du pays fin fevrier.

Les medicaments- nevirapine, stavudine and lamivudine - des generiques, sont
arrives au magasin central d'Oshodi à Labos la semaine derniere. Il y en a
pour 250 millions de Nairas (a peu pres 2 millions de dollars).

Ceci est confirme par le coordinateur du reseau des pwas qui est venu
constater les faits sur place.

L'arrivee des traitements met un terme a l'anxiete ressentie par les 14000
nigérians qui etaient censes beneficier de ce programme, et dont nombre
d'entre eux ont du interrompre leur regime a la fin de l'annee derniere
faute de medicaments.

(...)

Egalement confirme par le Dr. Oni Idigbe, de  Nigerian Institute of Medical
Research (NIMR), qui a dit a notre reporter que des procedures
bureaucratiques etaient a l'origine du retard dans l'approvisionnement, plus
de trois mois qpres que le President Obasanjo ait approuve une ligne
budgetqire de 500 million de Nairas.

Idigbe, qui est aussi membre du comite national de conseil, a dit que malgre
l'approbation de la requete du ministre de la sante en novembre par le
president, des officiels du ministere des finances on insiste pour que
l'approbation suive les procedures officielles bla bla (note de la
traductrice). Apres que cet obstacle ait ete leve, le ministere des finances
a annonce qu il ne disposait pas du cash... Il a fallu que le president
approuve le deboursement de la moitie de la somme precedemment prevue pour
que les 250 millions de nairas soient debourses.

Afin d'eviter la recurrence de ce genre de rupture, le comite ARV a
recommende la decentralisation du systeme de distribution, qui garantira que
les centres emettent leurs demandes en direct aux magasins a chaque fois que
se presentera un probleme de stock limite.

De plus, un comite technique a aussi ete mis en place pour evaluer le niveau
de resistance developpe par les personnes atteintes qui ont interrompu leurs
traitements. Les conclusions du comite devront guider le gouvernement vers
des alternatives de deuxieme ligne appropriees qui seront accessibles pour
ceux qui auront developpe des resistances au traitement de premiere
ligne.

...

L'article a ete poste sur e forum le 18 fevrier.

Marie de Cenival.

******************

------ Message transféré
> De : Olayide Akanni <olayide@nigeria-aids.org>
> Répondre à : eforum@nigeria-aids.org
> Date : Wed, 18 Feb 2004 03:56:44 -0500
> À : "Nigeria-AIDS eForum" <eforum@nigeria-aids.org>
> Objet : [eforum] Fresh supplies of ARVs boost Nigeria's treatment
programme
>
> Finally, fresh supplies of ARVs arrive
> As ARV programme gets new manager
>
> By Olayide Akanni
> Access Alert newsletter
> January/February 2004
>
> After several months of scarcity, fresh supplies of
> antiretroviral drugs for Nigeria's tottering HIV/AIDS
> treatment programme are now available. They are expected to
> reach the 25 treatment centers across the country by end
> February.
>
> The drugs - nevirapine, stavudine and lamivudine - generic
> versions of antiretroviral treatment for people living with
> HIV, arrived the Central Medical Stores in Oshodi, Lagos
> last week. They are worth 250 million naira (or about
> US$2million).
>
> Coordinator of the Network of People Living with HIV in
> Nigeria (NEPWHAN), Dr. Pat Matemilola, who was at the
> Oshodi central stores last week Tuesday, confirmed the
> development.
>
> The drugs arrival would put an end to the anxiety of over
> 14,000 Nigerians living with HIV on the treatment
> programme, many of whom were forced to interrupt their
> regimen when supplies ran out in most of the centres late
> last year. In addition to depleted stocks, distribution of
> expired drugs and inadequacy of trained personnel had been
> some of the major problems threatening to jeopardize the
> gains of the national treatment programme.
>
> Before the drug stock-out, the programme, which commenced
> in January 2002, was widely hailed as one of Africa's most
> ambitious national treatment programmes.
>
> Also confirming the arrival of the drugs, Dr. Oni Idigbe,
> Director-General of the Nigerian Institute of Medical
> Research (NIMR), told our reporter last Sunday that
> bureaucratic procedures caused the delay in the purchase of
> the drugs, more than three months after President Olusegun
> Obasanjo approved a lifeline of N500 million for  that
> purpose.
>
> Idigbe, who is also a member of the national ARV advisory
> committee, said that although the president had approved
> the N500 million request made by the Ministry of Health
> last November for the purchase of the drugs, finance
> ministry officials insisted that the approval had to go
> through 'due process'. After that obstacle was cleared, the
> finance ministry said that the approval did not have the
> required 'cash backing'. It took presidential approval for
> a 50 per cent waiver, before the ministry released the sum
> of N25O million for the purchase of the drugs.
>
> To avoid a recurrence of supplies shortage as was witnessed
> in the last three months, the ARV committee has recommended
> a decentralization of the drug distribution system, which
> will ensure that treatment centres make direct request to
> the stores themselves whenever they are in short supply,
> our reporter learnt.
>
> In addition, instead of wholesale advance purchase of a
> year's supplies (a development that led to the issuance of
> expired drugs), quarterly purchases would be made.
>
> A technical committee has also been set up to assess levels
> of resistance developed by PLWA who had interrupted
> treatment as a result of the ARV stock-out. The committee??s
> findings are expected to guide government on appropriate
> second line regimens to be made available for those shown
> to have developed resistance to the first-line drugs.
>
> In a related development, Dr. Nasir Sani-Gwarzo, deputy
> director in the federal ministry of health who was directly
> in charge of the ARV programme, has been redeployed to a
> new position. He is now to head the ministry's tuberculosis
> and leprosy control programme. Dr. (Mrs) Salawu, formerly
> heading the malaria programme, will now run the ministry??s
> HIV/AIDS response team, including the ARV programme. The
> changes, which were described as 'routine', took effect
> from this week.
>
> *Access Alert newsletter is published by Journalists
> Against AIDS (JAAIDS) NIgeria (with support of the Ford
> Foundation). Olayide Akanni can be reached at:
> olayide@nigeria-aids.org
>
> ---
> You are currently subscribed to the Nigeria-AIDS eForum
> (eforum@nigeria-aids.org)
> To unsubscribe, send a blank email to: unsubscribe-eForum@nigeria-aids.org
> To subscribe, send a blank email to: subscribe-eForum@nigeria-aids.org
> View message archives at http://www.nigeria-aids.org/eforum.cfm
>
> The Nigeria-AIDS eForum is a project of Journalists Against AIDS (JAAIDS)
> Nigeria.
> For more information about us, visit our website:
http://www.nigeria-aids.org
> Contact the eForum moderator at: moderator1@nigeria-aids.org

--
Adresse pour les messages destinés au forum E-MED:
e-med@healthnet.org
Pour répondre à un message envoyer la réponse au forum
ou directement à l'auteur.
Pour vous inscrire, vous désinscrire et consulter les archives de e-med:
http://www.essentialdrugs.org/emed/
Pour toutes autres questions addresser vos messages à:
e-med-help@healthnet.org